Liquid-filled capsule technology has a proven record for addressing complex API formulation challenges, but also offers a simple and effective pathway to the clinic. The capsules can be used with an array of pharmaceutically approved lipid-based excipients, offering formulation flexibility from LFCS type I to type IV and effective API containment.

Register now to learn about the details of scaling up safely for highly potent API.